A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01770613
Recruitment Status : Withdrawn (Corporate business decision, may consider different subject population)
First Posted : January 18, 2013
Last Update Posted : April 27, 2017
CardioCell LLC
Information provided by (Responsible Party):
Stemedica Cell Technologies, Inc.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : May 2016
  Estimated Study Completion Date : May 2017